Integra Lifesciences Holdings (IART) Revenue (2009 - 2026)

Integra Lifesciences Holdings has disclosed Revenue across 18 years of filings, most recently posting $418.8 million for Q2 2026.

• In Q2 2026, Revenue rose 0.76% year-over-year to $418.8 million; the TTM figure through Jun 2026 stood at $1.6 billion (up 1.6% YoY), while the FY2025 annual figure was $1.6 billion, up 1.53% from the prior year.
• Revenue came in at $418.8 million for Q2 2026 at Integra Lifesciences Holdings, up from $391.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $442.6 million in Q4 2024 to a low of $368.9 million in Q1 2024.
• Average Revenue over 5 years is $397.5 million, with a median of $394.5 million recorded in 2023.
• Year-over-year, Revenue dropped 4.16% in 2023 and climbed 11.49% in 2024.
• Over 5 years, Revenue stood at $398.0 million in 2022, then declined by 0.25% to $397.0 million in 2023, then rose by 11.49% to $442.6 million in 2024, then dropped by 1.74% to $434.9 million in 2025, then dropped by 3.72% to $418.8 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $418.8 million in Q2 2026, $391.9 million in Q1 2026, and $434.9 million in Q4 2025.